Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Converting p53 from a killer into a healer

Andrei V Gudkov

    Nature Medicine
    |November 2, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPF.

    Science translational medicine·2026
    Same author

    The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells.

    bioRxiv : the preprint server for biology·2026
    Same author

    A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomas.

    Surgical oncology·2025
    Same author

    The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.

    Proceedings of the National Academy of Sciences of the United States of America·2025
    Same author

    Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

    bioRxiv : the preprint server for biology·2024
    Same author

    Enhancing Anti-PD-1 Immunotherapy by Targeting MDSCs via Hepatic Arterial Infusion in Breast Cancer Liver Metastases.

    Cancers·2024
    Same journal

    Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents.

    Nature medicine·2026
    Same journal

    Spatiotemporal diffusion of the 2024 Oropouche outbreak in Cuba.

    Nature medicine·2026
    Same journal

    Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

    Nature medicine·2026
    Same journal

    Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

    Nature medicine·2026
    Same journal

    Data rights are the missing pillar for modernizing consent in medicine.

    Nature medicine·2026
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    See all related articles